Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer Makes Management Changes | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Pfizer Makes Management Changes

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer has made changes to the management of its U.S. Drug Unit. Peter Brandt has been named executive vice president of U.S. Pharmaceuticals. He reports to J. Patrick Kelly, who remains president of the unit. Mr. Brandt will take on responsibility for sales and marketing in the U.S. Mr. Kelly has taken on strategic planning, business development and other roles that had belonged to Mr. Brandt.

Mr. Kelly joined the company in 1981. After a series of marketing posts, he was made president of the U.S. Pharmaceuticals Group in 2002. Mr. Kelly was involved in the launch and marketing of some of Pfizer’s most successful products, including Lipitor, Viagra and painkiller Celebrex.

A Pfizer spokesman said, “We are redeploying a number of key executives.” A major thrust of the plan is “a more intense focus on the U.S. market because of its size and critical importance,” the spokesman said.

In response to competition from generics and branded products, Pfizer has begun cutting costs, pledging to trim $4 billion in annual spending by 2008.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters